Clearmind Medicine Inc (CMND) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CMND Annual Balance Sheets →
Quarterly balance sheet trends provide context on Clearmind Medicine Inc's liquidity, leverage, and long-term financial structure.
Quarterly Report, GAAP in USD millions
ITEM
(Jan 31 2026)
(Oct 31 2025) 0 0 0
Assets
Cash And Cash Equivalents6.83
Cash & Short-term Investments6.00
Other Current Assets0.00
Total Current Assets8.13
Intangible Assets0.09
Other Assets, Noncurrent1.30
Total Assets8.22
Liabilities
Other Liabilities, Current0.00
Total Current Liabilities2.14
Total Long-term Debt0.00
Other liabilities, Noncurrent2.14
Total Liabilities2.14
Stockholders' Equity
Other Equity0.00
Common Stockholder's Equity6.08
Total Stockholder's Equity6.08
Liabilities & Stockholder's Equity8.22
4 historic quarters locked

Sign in to unlock the full Clearmind Medicine Inc balance sheet history.

About Clearmind Medicine Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-005665

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.